The UK is studying cases of pancreatitis in people taking drugs based on GLP-1 receptor agonists for weight loss or type 2 ...

There are growing concerns about the side effects caused by weight loss injections such as Ozempic, Wegovy and Mounjaro.

U.K. regulators have launched a study into a possible genetic link between use of GLP-1s, such as Ozempic, Mounjaro and Wegovy, and acute pancreatitis. Yellow Card Biobank, a joint initiative of ...

A study has been launched into the side effects of weight-loss jabs after ten people have died and hundreds contracted ...

Weight loss drugs are exploding in popularity across the country with many calling them game-changers when it comes to treating obesity and all the medical cond ...

Viking begins phase III VANQUISH program for VK2735, targeting weight loss in obese adults with or without type II diabetes.

Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...

Employers who fail to account for these experiences risk missing a critical part of the employee wellness equation.

Eli Lilly bets on next-generation obesity candidates like orforglipron and retatrutide to sustain growth amid rising ...

Novo Nordisk shares have come under pressure amid weight-loss drug competition, while UK health officials have launched a ...

As host of the Netflix reality competition show “ Nailed It! ” she presided over home baker contestants and their very ...

Data show an alarming number of deaths have been linked to weight loss jabs approved by the NHS, with drugs like Ozempic, Wegovy and Mounjaro accounting for the majority.